Production of Antibiotics
Production of Antibiotics
Production of Antibiotics
The Production of Antibiotics has been widespread since the pioneering efforts of
Florey and Chain in 1938. The importance of antibiotics to medicine has led to much
research into discovering and producing them.
Contents
[hide]
• 4 References
Despite the wide variety of known antibiotics, less than 1% of antimicrobial agents have
medical or commercial value. The most commonly known antibiotic, Penicillin has a
highly selective toxicity and therapeutic index (as eukaryotic animal cells do not contain
peptidoglycan, they are usually unaffected by it). This is not so for many antibiotics.
Others simply lack advantage over the antibiotics already in use, or have no other
practical applications.
In order to identify the useful antibiotics, a process of screening is often employed. Using
this method, isolates of a large number of microorganisms are cultured and then tested for
production of diffusible products which inhibit the growth of test organisms. However,
the majority of the resulting antibiotics are already known and must therefore be
disregarded. The remainders must be tested for their selective toxicities and therapeutic
activities, and the best candidates can be examined and possibly modified.
A more modern version of this approach is a rational design program. This involves
screening being directed towards finding new natural products that inhibit specific targets
(e.g. a particular step of a metabolic pathway) on microorganisms, rather than tests to
show general inhibition of a culture.